Medical Arts Center, 11 Overlook Rd., Suite 140, Summit, NJ 07901 Tel: 908-273-7770
Autistic Spectrum Disorders (Including Asperger's Syndrome, Pervasive Development Disorder (PDD), and Attention Deficit Disorder)
Candida/Yeast Treatments
Chronic Fatigue Syndrome
Chronic Fatigue HHV-6 Treatment
Chronic Fatigue Syndrome Disability
Depression
Fibromyalgia
Fibromyalgia Disability
Hypoglycemia
Postherpetic Neuralgia (PHN)/Shingles
Migraine Headaches and Treatments
Stress and Anxiety
Thyroid and Hypothyroidism
Resources
Information for New Patients
New Patient Information Forms (PDF)
Reversing Eight Vicious Cycles That Block Normal Healing
Safety Concerns
Recent Updates
Our New Jersey Offices
Serving patients from New Jersey (NJ), New York (NY), Pennsylvania (PA), and Connecticut (CT)
Dr. Jose Montoya, a chronic fatigue syndrome physician at Stanford Medical School, treated 25 chronic fatigue syndrome (CFS) patients with Valcyte, an oral medicine that blocks HHV-6, Epstein Barr virus and other Herpes family viruses.[1]
Spectacularly, 21 of 25 patients dramatically improved. Most achieved near resolution of their CFS symptoms after a six month course of treatment. This allowed return to work or other full-time activities. Of those whose CFS had begun with a flu-like illness, 20 out of 21 gained improved health.
For the Abstract of Dr. Montoya’s article on chronic fatigue syndrome HHV-6 treatment This is the National Library of Medicine’s website. In the search space type the words — chronic fatigue syndrome Montoya Valcyte. Click Here.
For an update on Dr. Montoya’s more recent progress, this will take you to Stanford Medical School’s website. Enter search terms Montoya and fatigue. Then click on the on the title New Therapy For Chronic Fatigue Syndrome Click Here.
If confirmed by further studies, Dr. Montoya’s research tells us two important facts:
o HHV-6 and/or Epstein Barr Virus can cause Chronic Fatigue Syndrome o Valcyte might be an effective treatment for Chronic Fatigue Syndrome HHV-6 related illness, perhaps, even a chronic fatigue syndrome cure.
o HHV-6 and/or Epstein Barr Virus can cause Chronic Fatigue Syndrome
o Valcyte might be an effective treatment for Chronic Fatigue Syndrome HHV-6 related illness, perhaps, even a chronic fatigue syndrome cure.
[1] (HHV 6 stands for Herpes Virus 6, the sixth virus in the Herpes family. The standard spelling is HHV-6, but we also see it as HHV 6 and HHV6. Chronic fatigue syndrome physicians believe that Chronic Fatigue Syndrome HHV-6 may affect up to 50% of CFS patients. Other Herpes family viruses include Epstein Barr virus (EBV), Cytomegalovirus (CMV), Herpes Simplex (oral and genital) and also chicken pox virus (Varicella Zoster).
Structure of the HHV-6 virus. Anti-viral treatment for Chronic Fatigue Syndrome HHV-6 increases hope chronic fatigue syndrome cure.
Roche Pharmaceuticals recently gave Dr. Montoya and his chronic fatigue syndrome physician team $1.3 million to do a double-blind study to confirm Valcyte’s effectiveness as a chronic fatigue syndrome HHV-6 treatment. However, results might not be available for at least a year or more
back to top
Chronic fatigue syndrome physicians are concerned about this problem: Since almost everyone has had an HHV-6 infection at some point, latent inactive HHV-6 is present in most of us. That’s why perhaps 80% of healthy people show up positive on standard blood antibody tests for HHV-6. But, while for most people HHV-6 remains inactive for life, chronic fatigue physicians believe that in a few people a triggering event happens. This causes latent virus to become active, aggressive and infectious. The result: chronic fatigue syndrome HHV 6 –active CFS!
Chronic Fatigue Syndrome HHV-6 Pathways: How Latent Virus Infection can turn into symptomatic, active CFS Illness. Can HHV-6 treatment be a chronic fatigue syndrome cure? (Courtesy of the Wisconsin Viral Research Group)
Click Picture For Larger View
Blood antibody tests for HHV-6 are available through many commercial laboratories. Such blood antibody tests are helpful but not definitive. Many people are positive for HHV-6; but the higher the antibody levels, the odds increase that you might have active chronic fatigue syndrome HHV-6. But the antibody test is far from perfect. Some persons with relatively low antibody levels have active HHV-6. Some people with high antibody levels don’t.
Blood Culture and Antigen test for HHV-6: The Wisconsin Research Group offers a Herpes virus culture test. Their lab is the best for HHV-6 testing. While standard antibody tests against HHV-6 also should be done, the Wisconsin test may be more accurate. Ideally you should have the standard test and also the Wisconsin test before making a decision about Valcyte treatment for CFS.
Nested PCR: The Wisconsin Viral Research Group also offers a sophisticated test to detect actual virus particles in the blood. This is called nested PCR. The Wisconsin Viral Research Group version is more sensitive and accurate than the standard PCR.
If you have high HHV-6 antibody levels and a positive Herpes Virus 6 culture, consider the pros and cons of Valcyte treatment for your chronic fatigue syndrome.
For more information on chronic fatigue syndrome HHV-6 testing visit the website of the HHV-6 Foundation.
For the Wisconsin Viral Research Group visit chronic fatigue syndrome HHV-6 Testing.
Valcyte’s side effects can also include nausea, diarrhea, abdominal pain, fever, headache, insomnia, mood changes, tingling sensation--and much less commonly, epileptic seizures. In animal studies, ganciclovir can cause cancer.
A good question, and there’s a good answer. We have no effective drug treatments for chronic fatigue syndrome at present. If your illness is severe enough, the potential benefit from Valcyte treatment for chronic fatigue syndrome HHV6, might reasonably be considered to be worth the potential risk. That’s the key decision that you and your physicians have to make.
Consider this analogy to chronic fatigue syndrome HHV 6. If you had cancer or disabling rheumatoid arthritis or chronic hepatitis, specialists routinely recommend medicines that are as or more toxic than Valcyte. So too for chronic fatigue syndrome HHV 6. One weighs the risks of adding Valcyte treatment against the risks of not treating and letting the disease “take its course”. Not an easy decision—since until double blind studies are done we can’t really know if this anti-viral drug might be a chronic fatigue syndrome cure.
As a chronic fatigue syndrome physician, I recommend that persons whose CFS allows them a decent quality of life should not take Valcyte at this time. But, do test blood antibodies and/or Herpes virus culture. Keep up to date on this potential treatment option, especially as safer anti Herpes drugs become available.
For the most reliable and up-to-date information about chronic fatigue syndrome HHV-6 go to www.Pubmed.gov — the data base site for the National Library of Medicine. Enter the keywords Chronic Fatigue Syndrome HHV-6, and/or Chronic Fatigue Syndrome Treatment HHV-6.
While waiting for further news consider adding relatively non-toxic natural immune system stimulants to your chronic fatigue syndrome treatment program e.g. high dose Lactobacillus Acidophilus, HHV-6 transfer factor, or Fungal cell wall immune stimulants such as AHCC or Peak Immune Factor 4.
Do CONSIDER Valcyte treatment for chronic fatigue syndrome HHV-6 if your CFS is severe and disabling. We don’t have double blind studies; but the encouraging results Dr. Montoya reported should make us optimistic that Valcyte, indeed, might be a useful treatment.
In our New Jersey (NJ) office, we take these steps to evaluate an individual’s potential use of Valcyte for Chronic Fatigue Syndrome HHV6 Treatment:
Confirm that you really have chronic fatigue syndrome, not one of the many other conditions that can mimic CFS.
Look for other treatable aspects of your illness e.g. unrecognized low thyroid, sleep apnea, adrenal gland problems, inadequate nutrition, anxiety or depression.
Add natural holistic nutritional, herbal and/or mind-body treatments to support the body’s natural ability to heal.
Be sure that social and psychological supports are in place to help you and your family cope better with the illness.
Test HHV-6 antibody levels and HHV-6 culture and antigen tests.
Ask you to read the FDA-approved drug package insert for Valcyte. (Click Here for Valcyte Treatment for Chronic Fatigue Syndrome Package Insert)
Before starting Valcyte through Dr. Podell’s offices in Springfield or Somerset New Jersey (NJ) CFS patients should agree to a firm schedule of regular laboratory test monitoring. Valcyte patients would see Dr. Podell at least monthly during an estimated six month course of treatment. Blood test monitoring for Valcyte toxicity is twice weekly for the first six weeks, then once every week.
For persons with chronic fatigue syndrome HHV6 or EBV who live in New York (NY), Pennsylvania (PA) or more than one hour away from our Springfield or Somerset New Jersey (N.J.) offices, Dr. Podell can perform the necessary evaluation for chronic fatigue syndrome HHV-6 within two or three visits. Dr. Podell can then consult with a physician near you, who, if you decide to take Valcyte, can directly supervise the treatment.
Also Visit:
Our Chronic Fatigue Syndrome Main Page
Chronic Fatigue Syndrome HHV-6 patient information handout
Video provided by WNBC
Please note: Physicians are not permitted to give specific advice or answer medical questions for individuals who have not been evaluated as patients